Treatment of pancreatic adenocarcinoma: a European perspective.
The diagnostic strategy/staging, surgical management, and adjuvant treatment of pancreatic cancer have changed worldwide during the past decades. These changes are discussed in this article. Specific attention is given to European studies and contributions.
Gouma
Dirk J
DJ
Department of Surgery, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. d.j.gouma@amc.uva.nl
Busch
Olivier R C
OR
van Gulik
Thomas M
TM
D000230:Adenocarcinoma / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D005060:Europe; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D009367:Neoplasm Staging; D010166:Palliative Care / Q000379:methods; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D019936:Probiotics / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D013004:Somatostatin / Q000627:therapeutic use
D006728:Hormones; D013004:Somatostatin